Article info

Download PDFPDF

Extended report
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

Authors

  1. Correspondence to Susan Manzi, Allegheny Singer Research Institute, West Penn Allegheny Health System, Temple University School of Medicine, Pittsburgh, Pennsylvania 15224, USA; smanzi{at}wpahs.org
View Full Text

Citation

Manzi S, Sánchez-Guerrero J, Merrill JT on behalf of the BLISS-52 and BLISS-76 Study Groups, et al
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

Publication history

  • Accepted February 25, 2012
  • First published May 1, 2012.
Online issue publication 
October 05, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.